Thyroid eye disease, also known as Graves' ophthalmopathy or Graves' orbitopathy, is an autoimmune disorder where the muscles and fatty tissues behind the eyes become inflamed as a result of an autoimmune disorder of the thyroid gland.
Causes of Thyroid Eye Disease
Thyroid eye disease is caused by an autoimmune process where the body's immune system mistakenly attacks the eye muscles and surrounding fatty tissues. This condition is commonly associated with Graves' disease, an autoimmune disorder of the thyroid gland where the gland becomes overactive and produces excess thyroid hormones. Though the exact cause is unknown, genetics and environmental triggers are believed to play a role in development of the autoimmune response.
Symptoms of Thyroid Eye Disease
Common symptoms of Thyroid Eye Disease Treatment include swelling or bulging of the eyes, dryness and itchiness, double vision, redness of the eyes, sensitivity to light and blurring of vision. In severe cases, the eyes may appear to be stuck in one position and prevent from moving properly. Vision loss is rare but can occur in advanced stage of the disease.
Diagnosis of Thyroid Eye Disease
A complete eye examination by an ophthalmologist along with tests like CT scan or MRI of the orbits may help identify symptoms and extent of swelling behind the eyes. Blood tests to check thyroid function can confirm if the patient has Graves' disease or other thyroid disorders associated with thyroid eye disease.
Treatment Options for Thyroid Eye Disease
Mild cases are typically managed with artificial tears to relieve dryness and corticosteroids in the form of eye drops or pills to reduce inflammation. Severe inflammation may require stronger medications like immunosuppressive drugs. In cases with severe proptosis or dysthyroid optic neuropathy, orbital decompression surgery may be performed to remove fatty tissues and relieve pressure behind the eyes. Radiation therapy may also provide benefits in reducing inflammation and swelling in some patients.
Lifestyle Management for Thyroid Eye Disease
Following a healthy lifestyle can help manage symptoms of thyroid eye disease. Getting adequate sleep, managing stress through yoga or meditation, and a diet rich in omega-3 fatty acids, vitamins A, C and E offer antioxidant support. Cool compress may temporarily alleviate discomfort. Integrating gentle eye exercises into daily routine helps avoid adverse effects of immobilization due to inflammation. Quitting smoking is also important as it exacerbates symptoms and slows healing. Regular follow ups with ophthalmologist help to track disease progression and modify treatment accordingly. With appropriate medical management, thyroid eye disease can be effectively managed in majority of cases.
Prognosis for Thyroid Eye Disease
The good news is thyroid eye disease symptoms often improve as the underlying thyroid condition is brought under control. While effects may persist, timely treatment offers best outcomes. With mild cases, complete resolution is likely. However, those with severe and long-standing disease may have permanent changes requiring ongoing management. Early diagnosis and treatment by a team of ophthalmologist and endocrinologist optimizes outcomes in thyroid eye disease.
Get more insights on Thyroid Eye Disease Treatment
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the dry eye disease treatment market include Bausch + Lomb, Akorn Inc., Novartis AG, Alimera Science, Allergan plc., Santen Pharmaceutical Co. Ltd, Auven Therapeutics, GlaxoSmithKline plc, Nicox S.A., and Otsuka Holdings Co. Ltd.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Dry Eye Disease Treatment Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/dry-eye-disease-treatment-market/download-sampleMarket DynamicsExcessive use of smartphones & computers, expanding aging population, which is highly prone to the syndrome, and other risk factors are steering the dry eye disease treatment market.
As per World Population Prospects 2019 estimates, around 9% of the global population is over 65 years of age, and by 2050 this is expected to account for nearly 17% of the worldwide population.
Expanding prevalence of these diseases will tend to cause a rise in the incidence of dry eye disease.
Increasing awareness levels, rising diagnostic rates, availability of better treatment options are other factors augmenting the market's growth.
